INTRODUCTION AND OBJECTIVES: While the overall rate of deep venous thrombosis (DVT) or pulmonary embolism (PE) following robotic assisted radical prostatectomy (RARP) is low, perioperative anticoagulation (AC) is often recommended to prevent morbidity from venous thromboembolic events (VTE). We sought to evaluate the incidence and course of DVT and PE following RARP at our institution, comparing men who received perioperative enoxaparin to those who received no AC, and hypothesized that the VTE rate would be equivalent.
INTRODUCTION AND OBJECTIVES: While the overall rate of deep venous thrombosis (DVT) or pulmonary embolism (PE) following robotic assisted radical prostatectomy (RARP) is low, perioperative anticoagulation (AC) is often recommended to prevent morbidity from venous thromboembolic events (VTE). We sought to evaluate the incidence and course of DVT and PE following RARP at our institution, comparing men who received perioperative enoxaparin to those who received no AC, and hypothesized that the VTE rate would be equivalent.
METHODS: A hospital system-wide database was queried from January 2006-August 2018 for patients undergoing RARP, who were stratified by the practice of the surgeon: AC (single preoperative subcutaneous injection of enoxaparin) versus no AC. Demographic and perioperative data were compared. The records of men who experienced VTE (DVT or PE) within 6 months of RARP were examined.
RESULTS: A total of 5,772,759 medical records were queried during the study period, of which 3097 men underwent RARP. Most men (2098/3097) received care by a surgeon who did not utilize perioperative AC. As compared to patients receiving AC, the incidence of VTE was comparable (Table 1) . Men who had VTE but did not receive preoperative AC (26/2098) were reviewed. Median time to presentation with VTE was 11 days (IQR 5-28) and median length of stay was 1 day (IQR 1-4). Of these patients, 6/26 had history of VTE prior to undergoing RARP and 5/26 remained on lifelong AC following VTE.
CONCLUSIONS: In a hospital system-wide review of a highvolume surgical practice, the administration of a single preoperative dose of enoxaparin does not appear to affect the rate of VTE following RARP. Limitations of this analysis include incomplete data on parameters such as operative time, and lack of uniform follow-up; nevertheless, the rate of VTE was overall low The purpose of our study is to report on our experience with radiofrequency ablationassisted, clampless, robotic partial nephrectomy (RFA-CRPN), which allows for intraoperative pathology evaluation without concerns for warm ischemia time (WIT).
METHODS: 187 consecutive patients with 195 renal masses underwent RFA-CRPN with intraoperative pathology evaluation. Average R.E.N.A.L. nephrometry score was 7.0. Intraoperative imaging was used to delineate the mass and renal parenchymal thickness. The Habib 4x radiofrequency ablator with the 1500 Rita generator was used to establish a 1-cm zone of coagulation around the mass. Sharp dissection and bipolar cautery was used to excise the mass. Frozen section confirmation of margin status was obtained in all cases. Mean follow up was 34 months (1-106 months).
RESULTS: All masses were excised without the need to clamp the renal vasculature. Median operative time was 184 minutes; median blood loss was 150 ml. A negative margin was obtained in all malignant cases. Median length of stay was two days. Four of 187 patients had urine leaks, which were managed with either prolonged percutaneous drainage or ureteral stent placement. We observed no statistically significant decrease in renal function measured in the late postoperative (>24 months) period (p[0.086). Radiographic follow up available in 171 patients showed no local tumor recurrences, strictures, or hydronephrosis.
CONCLUSIONS: Our study demonstrates the feasibility of performing a truly clampless robotic partial nephrectomy. Our technique allows the surgeon to operate in a nearly bloodless field without the time constraints imposed by renal vasculature clamping. This technique minimizes nephron loss, eliminates WIT and results in a very low urinary leak rate while allowing for confirmation of negative intraoperative surgical margins.
